Aarti Pharmalabs Ltd

Aarti Pharmalabs Ltd

Next 500 2024
OVERVIEW
FINANCIALS

About

Aarti Pharmalabs is a leading manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), serving global pharmaceutical companies. With expertise in complex chemistries and value-added products, the company plays a crucial role in the pharmaceutical supply chain. Aarti Pharmalabs is known for its innovation-driven approach, ensuring high-quality, cost-effective solutions that meet stringent regulatory standards. Leveraging advanced research, robust infrastructure, and a strong commitment to sustainability, the company delivers customised solutions to support drug development and production worldwide. As a trusted partner in the industry, Aarti Pharmalabs continues to expand its global footprint while driving pharmaceutical innovation.

Incorporation Year: 2019
Headquarters: Mumbai, India
Top Management: Rashesh C. Gogri (MD)
Industry: Pharma

Featured In Fortune India Ranking

Next 500 India
#240(2024)
#240(2024)

Financial Data 2024

Revenue
1,877
(INR Cr)
Net Operating Income
1,853
(INR Cr)
Assets
2,048
(INR Cr)
Profit
217
(INR Cr)
Net Worth
1,757
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS20242023202220212020
Revenue
(INR Cr)
1877
-9.4%
2073
65.6%
1252
-
0
-
0
-
Net Operating Income
(INR Cr)
1853
-4.76%
1945
62.11%
1200
0.00%
0
0.00%
0
0.00%
Profit
(INR Cr)
217
12.1%
193
58.3%
122
-
0
100.0%
0
-
Assets
(INR Cr)
2048
15.1%
1779
3.0%
1728
-
0
0.0%
0
-
Net Worth
(INR Cr)
1757
12.7%
1558
12.4%
1386
-
0
0.0%
0
0.0%
Employee Cost
(INR Cr)
128
5.5%
121
42.4%
85
-
0
-
0
-
Interest Cost
(INR Cr)
17211200
Cash & Bank Balance
(INR Cr)
24128300
Total Debt
(INR Cr)
28521534100

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS20242023202220212020
Profit As % Of Revenues 11.6%9.3%9.8%--
Profit As % Of Assets 10.6%10.9%7.1%--
Profit As % Of Networth 12.3%12.4%8.8%--
Interest Cost to EBITDA % 4.5%6.2%5.8%--
Debt to Equity Ratio 0.160.140.250.09-
RONW 13.1%13.1%17.6%--
ROCE 16.6%16.1%19.4%0.0%0.0%